Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Gaetano BacciPiero Picci

Abstract

Evaluation of pattern of recurrences of 290 patients with an Ewing's sarcoma family tumor (ESFT), who relapsed after adjuvant or neoadjuvant chemotherapy. Retrospective analysis at a median follow-up of 16.6 years (range: 5-32) from the primary therapy. There were 378 recurrences, treated by surgery, and/or chemotherapy, radiotherapy, or only palliative treatments. At the last control 18 patients were alive and free of disease 2.5 to 20 years (median 12.1 year) from the last treatment, 4 were alive with uncontrolled disease, 2 died of second line chemotherapy-related toxicity, and 266 died of the tumor 4 months to 20.5 years from the first relapse (median 3.2 years). The 5-year event free survival after the last relapse and overall survival were 5.1 and 7.9%, respectively, and resulted significantly correlated with the time of first relapse, the site of first metastases, the treatment performed after relapse (all patients presently free of disease had been treated by surgery alone or combined with a second line chemotherapy) and for patients treated with neoadjuvant chemotherapy and locally by surgery, with the histologic response to preoperative chemotherapy. We confirm that the post-relapse outcome of patients with ESFT who r...Continue Reading

References

Oct 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·R SauerJ Michaelis
Mar 1, 1967·The Journal of Pediatrics·R F Phillips, N L Higinbotham
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A W CraftD Pearson
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G BacciK V Smith
Nov 21, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G BacciS Ferrari
Aug 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S BurdachH Juergens
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James S MiserHolcolmbe E Grier

❮ Previous
Next ❯

Citations

Apr 23, 2013·Current Oncology Reports·Kristen N Ganjoo, Shreyaskumar Patel
May 22, 2013·Current Oncology Reports·Nino RainussoJason T Yustein
Jul 7, 2011·The Journal of Laryngology and Otology·H A OsbornK Fung
Jan 7, 2009·Journal of Pediatric Hematology/oncology·Anne-Marie I LessardDamian E Dupuy
Mar 15, 2005·American Journal of Clinical Pathology·Cheryl M CoffinHolly Zhou
Jul 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M T MarinoK Scotlandi
May 16, 2013·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Mark D MurpheyMark J Kransdorf
Nov 24, 2012·Acta Oncologica·Joni A SerloMaija Tarkkanen
Nov 30, 2011·Seminars in Oncology·David R D'Adamo
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ido Paz-PrielAlan S Wayne
Aug 14, 2008·Expert Review of Anticancer Therapy·Alexander D Rapidis
Mar 1, 2014·Journal of Pediatric Hematology/oncology·Max J GordonKeith M Skubitz
Feb 24, 2011·Expert Review of Anticancer Therapy·Joseph Rosenthal, Anna B Pawlowska
Mar 8, 2013·American Journal of Clinical Oncology·Steven I RobinsonNadia N Laack
Apr 15, 2014·Pediatric Blood & Cancer·Meybrit RasperUta Dirksen
May 13, 2018·Skeletal Radiology·Ömer KasalakThomas C Kwee
Feb 2, 2010·The Journal of the American Academy of Orthopaedic Surgeons·Aditya V Maheshwari, Edward Y Cheng
Jul 2, 2020·OncoTargets and Therapy·Deepam PushpamBivas Biswas
Feb 25, 2021·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Alberto RighiAngelo Paolo Dei Tos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.